Anti-FDFT1, NT (Farnesyl-diphosphate Farnesyltransferase, Squalene Synthetase, SQS, SS, FPP:FPP farnesyltransferase)Art Nr.: F3978-10, USBio
Tel:+49-40 - 85 32 600
0800 - 24 66 651 free call
Fax: +49-40 - 85 32 60-22
0800 - 24 66 652 free call
||E B IH
|FDFT1 catalyzes the first step in the cholesterol biosynthetic pathway, the conversion of trans-farnesyldiphosphate to squalene. The loss of promoter activity and response to sterols for FDFT1 is localized to a 69-bp section positioned 131 bp 5-prime to the transcription start site. Sequence analysis of this region shows that it contains a sterol regulatory element-1 (SRE1) previously identified in other sterol regulated genes and 2 putative NF1 binding sites. |
|Applications||Suitable for use in ELISA, Western Blot, and Immunohistochemistry. Other applications not tested.|
|Recommended Dilution||ELISA: 1:1,000|
|Western Blot: 1:100-1:500|
|Optimal dilutions to be determined by the researcher.|
|Storage and Stability||May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for at least 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.|
|Form||Supplied as a liquid in PBS, 0.09% sodium azide.|
|Purity||Purified by Protein G affinity chromatography.|
|Immunogen||Synthetic peptide selected from the N-terminal region of human FDFT1 (KLH).|
|Specificity||Recognizes human FDFT1. Species Crossreactivity: mouse.|
|Important Note||This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.|
This product is offered by Biomol for research purposes only.
Not for diagnostic purposes or human use.
It may not be resold or used to manufacture commercial products without written approval of Biomol GmbH.